Skip to search formSkip to main contentSkip to account menu

CI-719

Known as: CI 719, CI719 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Gemfibrozil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
The Hypolipidæmic Effect of Gemfibrozil (CI-719) in Laboratory Animals
In the search for compounds which decrease plasma lipids in man and animals, gemfibrozil was selected from a series of related… 
1976
1976
Lipokinetic Studies with Gemfibrozil (CI-719)
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and… 
1976
1976
Structure/Activity Relationship of Gemfibrozil (CI-719) and Related Compounds
Alkylation reactions are among the most fundamental and general procedures available to synthetic chemists for the purpose of… 
1976
1976
The Effect of CI-719 on Lipolysis in Rat Adipose Tissue
Clofibrate is an established hypolipidemic drug which lowers plasma triglyceride concentrations. The mechanism of its… 
1976
1976
Toleration and bioavailability of gemfibrozil in healthy men.
Gemfibrozil (CI-719) was recommended in March 1971, and approved by the Research Committee of Parke, Davis for clinical trial in… 
1976
1976
Summary of Present Data from a Clinical Trial of CI-719
Changes in triglycerides after four to eight weeks' intake of 800 mg of CI-719 are shown in Table 1. After four weeks a decrease… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)